Cancer Care Specialists of Central IL

Decatur, Illinois 62526

0 studies enrolling now · 3 studies all time

What they study most

Melanoma, Metastases, Non Small Cell Lung Carcinoma, Ovarian Neoplasms

Studies at this site

• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer — Completed
• MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma — Completed
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed